Monod Bio: Funding, Investors & Team (Oct 2026)
Monod Bio is a life sciences company developing biosensors for protein and other analyte detection. Its biosensor platform combines binding, transduction, and amplification to detect a range of target molecules. It utilizes recent advances in computational protein engineering to create highly modular bio-sensing nano switches that stimulate rapid, sensitive, and inexpensive analytical assays. Monod Bio was founded in 2021 and is headquartered in Seattle, Washington.
Monod Bio has raised $49.2M across 2 funding rounds on record, the most recent a Seed of $25.0M announced in Aug 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Monod Bio Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Monod Bio Funding Rounds
Monod Bio raised $24.2M in an undisclosed round announced in Jun 2022.
2 months later, a Seed of $25.0M was announced in Aug 2022.
Monod Bio Founders and Leadership Team
No contact details are on record for this team yet.
Monod Bio Funding Compared to Other Biotechnology Startups
Monod Bio's latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Monod Bio in Biotechnology and Seattle
Companies Similar to Monod Bio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Monod Bio Funding FAQs
What does Monod Bio do?
Monod Bio is a life sciences company developing biosensors for protein and other analyte detection. Its biosensor platform combines binding, transduction, and amplification to detect a range of target molecules. It utilizes recent advances in computational protein engineering to create highly modular bio-sensing nano switches that stimulate rapid, sensitive, and inexpensive analytical assays. Monod Bio was founded in 2021 and is headquartered in Seattle, Washington.
How much funding has Monod Bio raised?
Monod Bio has raised $49.2M across 2 rounds on record. The most recent is a Seed of $25.0M announced in Aug 2022.
When did Monod Bio last raise funding?
Monod Bio's most recent funding round on record is a Seed of $25.0M, announced in Aug 2022.
Who founded Monod Bio?
FundedIQ lists David Shoultz (Founder) at Monod Bio.
Who is the CEO of Monod Bio?
Daniel Adriano S is listed as CEO at Monod Bio.
Where is Monod Bio headquartered?
Monod Bio is based in Seattle, Washington, United States.
How many employees does Monod Bio have?
Monod Bio is in the 11-50 employee band.
How does Monod Bio's funding compare to other Biotechnology startups?
Monod Bio's latest round of $25.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Monod Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Monod Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.